TGFB1 and cancer: Other studies have shown that TGF-β/SMAD signaling inhibition can reduce MSC-CAF transformation and abolish the protumor effects of MSCs [96,101], highlighting the critical role of TGF-β signaling on MSC-CAF mediated cancer progression.